ETON
NASDAQ · Pharmaceuticals
Eton Pharmaceuticals Inc
$44.60
-1.58 (-3.42%)
Open$46.09
Previous Close$46.18
Day High$46.60
Day Low$44.55
52W High$50.18
52W Low$14.27
Volume—
Avg Volume516.4K
Market Cap1.24B
P/E Ratio—
EPS$-0.06
SectorPharmaceuticals
Analyst Ratings
Strong Buy
10 analysts
Price Target
-73.3% upside
Current
$44.60
$44.60
Target
$11.93
$11.93
$8.04
$11.93 avg
$13.91
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 79.91M | 51.38M | 122.17M |
| Net Income | -4,598,613 | -2,661,063 | 16.25M |
| Profit Margin | -5.8% | -5.5% | 13.3% |
| EBITDA | 3.20M | 1.95M | 25.36M |
| Free Cash Flow | — | — | 11.15M |
| Rev Growth | +55.5% | +55.5% | -8.5% |
| Debt/Equity | 1.17 | 1.17 | 0.20 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |